tirzepatide injections hamilton Weight Loss Maintenance therapy on semaglutide or

Ozempic and Wegovy are both forms of semaglutide, a drug originally developed for diabetes

FDA approval Both medications are approved by the U.S

hence, we cannot exclude the possibility that some patients have been given a diagnosis not included within this study

Participants who had already completed 20 weeks of semaglutide 2.4 mg titration (with roughly 10.6% weight loss at that point) were then randomized to either continue semaglutide or switch to placebo for another 48 weeks [3]

Many participants genuinely try to verify product quality through third-party testing, community-shared lab results, and careful dosing protocols